top of page
Exome Sequencing for
Neurodevelopmental Disorders
Recommended by Leading Medical Societies
44% of patients with neurological disorders have received a delayed or incorrect diagnosis.
It doesn’t have to be this way for your patients. Exome sequencing offers a comprehensive assessment that can reduce the time to diagnosis.
Leading medical societies recommend exome sequencing as a first-tier test.
The National Society of Genetic Counselors (NSGC), American College of Medical Genetics and Genomics (ACMG), and the American Epilepsy Society (AES) recommend exome for patients with conditions such as:
unexplained epilepsy
intellectual disability
congenital anomalies
global developmental delays
bottom of page